BOURSE DIRECT financials
BOURSE DIRECT
969500GFIL2Z81YKUM35 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Other income | €1.2M | €1.4M |
| Depreciation & amortisation | €3.4M | €3.4M |
| Operating profit (EBIT) | €26.6M | €26.0M |
| Profit before tax | €26.7M | €26.0M |
| Income tax expense | €6.9M | €6.7M |
| Profit for the year | €19.8M | €19.3M |
| — attributable to owners | €19.7M | €19.1M |
| — attributable to NCI | €91.0K | €154.0K |
| Total comprehensive income | €19.9M | €19.7M |
| Per share | ||
| Basic EPS | €0.38 | €0.37 |
| Diluted EPS | €0.38 | €0.37 |
| Cash flow statement | ||
| Net cash from operating activities | €19.7M | €20.8M |
| Income taxes paid | €6.8M | €6.8M |
| Net cash from investing activities | -€3.8M | -€4.5M |
| Net cash from financing activities | -€12.6M | -€16.0M |
| Dividends paid | €10.4M | €8.4M |
| Lease liability payments | €972.0K | €890.0K |
| Balance sheet | ||
| Total assets | €1.37B | €1.17B |
| Property, plant & equipment | €3.7M | €3.4M |
| Right-of-use assets | €2.6M | €3.5M |
| Intangible assets & goodwill | €21.1M | €21.1M |
| Cash & equivalents | €59.7M | €56.4M |
| Total equity | €88.7M | €80.5M |
| — attributable to owners | €88.7M | €80.1M |
| Non-controlling interests | €0 | €451.0K |
| Deferred tax liabilities | €0 | €0 |
| Derived metrics | ||
| Return on equity | 22.3% | 24.0% |
| Cash conversion ratio | 0.99× | 1.08× |
| Other reported items | ||
| Adjustments For Deferred Tax Expense | -€16.0K | €65.0K |
| Adjustments For Depreciation and Amortisation Expense | €3.4M | €3.4M |
| Adjustments For Fair Value Gains Losses | €56.0K | €20.0K |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | €82.0K | €0 |
| Adjustments To Reconcile Profit Loss Other Than Changes In Working Capital | €3.5M | €3.4M |
| Cash and Bank Balances At Central Banks | €0 | €0 |
| Comprehensive Income Attributable To Noncontrolling Interests | €91.0K | €155.0K |
| Comprehensive Income Attributable To Owners of Parent | €19.8M | €19.5M |
| Current Tax Assets | €33.0K | €0 |
| Current Tax Liabilities | €118.0K | €830.0K |
| Debt Instruments Held At Amortised Cost | €0 | €0 |
| Deferred Tax Assets | €916.0K | €900.0K |
| Deposits From Banks At Amortised Cost | €50.1M | €39.1M |
| Deposits From Customers At Amortised Cost | €1.17B | €1.00B |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | €10.3M | €8.3M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €125.0K | €148.0K |
| Dividends Recognised As Distributions To Owners Per Share | €0.20 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €0 | €0 |
| Equity and Liabilities | €1.37B | €1.17B |
| Fee and Commission Expense | €5.8M | €4.2M |
| Fee and Commission Income | €39.1M | €35.2M |
| Financial Assets At Fair Value Through Other Comprehensive Income | €0 | €0 |
| Financial Assets At Fair Value Through Profit Or Loss | €5.0M | €5.0M |
| Financial Liabilities At Fair Value Through Profit Or Loss | €0 | €0 |
| Gains Losses On Disposals of Noncurrent Assets | €0 | €20.0K |
| Gains Losses On Financial Assets At Amortised Cost | €0 | €0 |
| Gains Losses On Financial Assets At Fair Value Through Profit Or Loss | -€56.0K | -€20.0K |
| Impairment Loss Impairment Gain and Reversal of Impairment Loss Determined In Accordance With IFRS9 | €14.0K | €228.0K |
| Increase Decrease In Cash and Cash Equivalents | €3.3M | €306.0K |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | -€1.2M | -€1.3M |
| Increase Decrease Through Sharebased Payment Transactions | €0 | €0 |
| Increase Decrease Through Transfers and Other Changes Equity | -€18.0K | €0 |
| Increase Decrease Through Treasury Share Transactions | €0 | -€5.3M |
| Intangible Assets Other Than Goodwill | €8.5M | €7.5M |
| Interest Expense | €1.1M | €1.8M |
| Investment Accounted For Using Equity Method | €609.0K | €536.0K |
| Issue of Equity | €0 | €0 |
| Issued Capital | €12.9M | €13.2M |
| Lease Liabilities | €2.7M | €3.6M |
| Liabilities | €1.28B | €1.09B |
| Loans and Advances To Banks At Amortised Cost | €1.20B | €1.04B |
| Loans and Advances To Customers At Amortised Cost | €3.7M | €20.7M |
| Number of Shares Issued | 51.6M | 52.9M |
| Other Adjustments For Noncash Items | €0 | €0 |
| Other Comprehensive Income | €27.0K | €416.0K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | €0 | €0 |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €27.0K | €416.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | €0 | €0 |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €27.0K | €416.0K |
| Other Expense By Nature | €0 | €0 |
| Other Financial Assets | €76.1M | €53.9M |
| Other Financial Liabilities | €6.0M | €4.7M |
| Other Inflows Outflows of Cash Classified As Financing Activities | €0 | -€5.3M |
| Payments From Changes In Ownership Interests In Subsidiaries | €1.2M | €1.3M |
| Provisions | €2.7M | €2.6M |
| Reserve of Exchange Differences On Translation | €0 | €0 |
| Retained Earnings | €62.3M | €53.6M |
| Revenue From Interest | €36.8M | €39.9M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €82.0K | €0 |
| Share Premium | €13.6M | €19.3M |
| Trade and Other Payables To Trade Suppliers | €19.7M | €14.9M |
| Trade Receivables | €20.5M | €6.3M |
| Treasury Shares | €0 | €6.1M |
Every line item above is a fact tagged in BOURSE DIRECT's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.